Chinmay Jani, MD, describes how he counsels patients with and without a smoking history on a lung cancer diagnosis.
|Slideshows|July 21, 2015
Slide Show: Trends in Targeted Therapies and Immunotherapies
Author(s)OncoTherapy Network Staff
This slide show provides information on the present and future of targeted therapies and immunotherapies based on a report from the IMS Institute for Healthcare Informatics.
Advertisement
References:
- IMS Institute for Healthcare Informatics. (2015). Developments in Cancer Treatments, Market Dynamics, Patient Access and Value: Global Oncology Trend Report 2015.
Advertisement
Related to this article
Chinmay Jani, MD, discusses ASCO 2026 data on lung cancer trends in younger adults and why this group has been overlooked.
Chinmay Jani, MD, explains how air pollution and asbestos contribute to lung cancer deaths beyond tobacco.
Chinmay Jani, MD, highlights nonsmoking risk factors, the impact of lung cancer on younger populations, and the value of comprehensive molecular testing.
Dirk Schadendorf, MD, outlineed which patients with BRAF V600–mutant melanoma, including those with brain metastases, may be candidates for triplet therapy.
Advertisement
Advertisement
Trending on CancerNetwork
1
Real-World Teclistamab Shows Deep Responses in R/R Multiple Myeloma Cohort
2
ArteraAI Prostate Test Added to NCCN Guidelines for BCR After Prostatectomy
3
Adding Pembrolizumab to SBRT Does Not Improve EFS in Early-Stage NSCLC
4
Virtuoso Robotic System Earns FDA De Novo Nod for En Bloc Bladder Resection
5